Visual Intelligence

Better Decision Making for Clinicians and Machine Learning

Imago is transforming the imaging industry with a new approach to machine learning that will allow both the clinician and artificial intelligence engines to see what is really there and differentiate early stage cancer and other structural abnormalities potentially smaller than 1mm.
+

A New Level of Visual Intelligence

Patient has cancer that went undetected for years. With Imago’s software, the abnormality is apparent 4 years before it was diagnosed.

NOTE: Imago visualizations at different zoom levels for demonstration

Learn More

A Clearer Read on Dense Breasts

Imago’s software reveals the structure of the entire breast, including what dense tissue normally hides, providing a level of detail that cannot be identified with current mammographic technology.

Imago’s software “re-visualizes” the mammogram, revealing abnormalities and tissue structure (see right).
Imago’s software “re-visualizes” the mammogram, revealing abnormalities and tissue structure (see below).

Learn More

A True Picture of Breast Health

Reduce uncertainty by revisualizing the existing mammograms. Imago’s software will dramatically improve a clinician’s ability to identify all structures within the breast. The goal is to reveal abnormalities earlier and improve interpretation accuracy. This level of detail has the potential to provide clinicians significant and critical time advantage, thereby enabling better outcomes: fewer false positives and false negatives.

Learn More

Easy Clinical Adoption

1
2
3
4

Providing Benefits Across the Continuum of Care

 

 
 

What's New
at Imago

View All 
 
Industry News

08.01.18 – NCI study to compare 2D and 3D…

08.01.18 – NCI study to compare 2D and 3D…

08.01.18 – NCI study to compare 2D and 3D…

Read More 
 
Industry News

06.27.18 – New study confirms higher cancer rate in women with dense breast…

06.27.18 – New study confirms higher cancer rate in women with dense breast…

06.27.18 – New study confirms higher cancer rate in…

Read More 
 
Industry News

06.26.18 – False-Positive Breast Biopsies Cost $2 Billion…

06.26.18 – False-Positive Breast Biopsies Cost $2 Billion…

06.26.18 – False-Positive Breast Biopsies Cost $2…

Read More 
 

1, 2 Susan G. Komen Breast Cancer Foundation https://ww5.komen.org/Breastcancer/Highbreastdensityonmammogram.html

3, 4 “National Expenditure for False-Positive Mammograms and Breast Cancer Overdiagnoses Estimated at $4 Billion a Year.” https://www.ncbi.nlm.nih.gov/pubmed/25847639